(Q73390428)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12745459%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

CD44s expression correlated with the International Neuroblastoma Pathology Classification (Shimada system) for neuroblastic tumours (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12745459%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

4

L. M. Looi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12745459

2 January 2024

author name string

M. J Julia Munchar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12745459

2 January 2024

N. A. Sharifah

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12745459

2 January 2024

R. Jamal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12745459

2 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12745459

2 January 2024

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12745459%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

3 November 2019

https://api.elsevier.com/content/article/PII:S0031302516343550?httpAccept=text/plain

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

https://api.elsevier.com/content/article/PII:S0031302516343550?httpAccept=text/xml

2 January 2024

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

2 January 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12745459%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12745459%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

125-129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12745459%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12745459%20AND%20SRC:MED&resulttype=core&format=json

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

3 November 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

Clinical strategies for the treatment of neuroblastoma

2 January 2024

5

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factors

2 January 2024

6

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas

2 January 2024

7

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

2 January 2024

8

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

2 January 2024

9

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma

2 January 2024

10

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma

2 January 2024

11

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

CD44 variant isoforms are preferentially expressed in basal epithelial of non-malignant human fetal and adult tissues

2 January 2024

12

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

Monoclonal antibody to a human brain-granulocyte-T lymphocyte antigen probably homologous to the W 3/13 antigen of the rat

2 January 2024

13

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

Expression of CD44 is repressed in neuroblastoma cells

2 January 2024

14

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons

2 January 2024

15

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

Splicing choice from ten variant exons establishes CD44 variability

2 January 2024

17

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family

2 January 2024

19

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins

2 January 2024

20

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44

2 January 2024

21

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

De-novo expression of CD44 and survival in gastric cancer

2 January 2024

22

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin

2 January 2024

26

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

Differentiation and prognosis of neuroblastoma in correlation to the expression of CD44s

2 January 2024

29

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

CD44--a new prognostic marker for neuroblastoma

2 January 2024

31

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

Role of CD44H carbohydrate structure in neuroblastoma adhesive properties

2 January 2024

32

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

2 January 2024

33

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

Significance of CD44 gene products for cancer diagnosis and disease evaluation

2 January 2024

35

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

CD44 and cancer screening

2 January 2024

36

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

Expression of CD44R1 adhesion molecule in colon carcinomas and metastases

2 January 2024

37

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44

2 January 2024

38

1 reference

https://api.crossref.org/works/10.1080/0031302031000082214

2 January 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12745459%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference